Share statistics

Share statistics (as at 30 June 2008)

Number of Ordinary Shares in issue (undiluted)

57,618,840

Number of Ordinary Shares subject to options

1,120,000

Maximum number of Ordinary Shares in issue (fully diluted)

58,738,840

The effect of the options, if all exercised, would be to increase the issued share capital by 1.94% and raise £686,625 gross for the Company.


Share volumes (as at 31 July 2008)

The daily average number of shares traded since the Company was first listed is:

Daily Average Per
Year Since Listing		   Daily Average Per
Month in 2008
2003 (since July) 84,514 Jan 83,222 July 38,631
2004 95,916 Feb 104,702    
2005 174,513 Mar 226,603    
2006 168,236 Apr 50,748    
2007 219,107 May 60,667    
2008 (to date) 85,156 June 47,654    
           

Share options (as at 30 June 2008)

The number of ordinary shares subject to options granted under the Share Option Schemes of the Company were:

Grant Exercise period (incl) Exercise Price/share No of share
options granted		 Cash to Company
on exercise
12/04 10/06 - 9/08 70p 50,000 £35,000
3/05 4/07 - 3/09 76p 280,000 £212,800
7/06 2/08 - 1/13 74.5p 200,000 £149,000
7/07 2/09 - 1/14 56.25p 300,000 £168,750
6/08 2/10 - 1/15 41.75p 290,000 £121,075
Totals     1,120,000 £686,625

Further details of share options issued before June 2008 can be obtained from the Company's Annual Report 2007 which can be found by following this link.


 

Page last up-dated: 13 August 2008

Page last reviewed: 12 August 2008

Major Shareholders
(as at 30 June 2008)

Institutions holding more than 3% of the share capital of Futura were:

  • Allianz Cornhill Insurance 7.1%
  • Deutsche Bank AG 4.4%
  • Gartmore Investment Management 4.4%
  • Jupiter Asset Management 3.2%

Other shareholders holding more than 3% of the share capital of Futura  were:

  • W T Lamb Investments Limited 7.3%
  • Medinvest Holdings Limited 7.0%
  • RA Lamb 6.9%
  • Christopher John Crabtree 6.0%

Shares not in public hands

In the terms of the AIM Rules published in February 2007 and insofar as it is aware, at 25 March 2008, 2.57% of the Company's AIM securities were not in public hands.

There are no restrictions on the transfer of Futura Medical securities.